Pridin Capsule 75 mg (Pregabalin)

Adult dose

This medication is administered orally divided into two doses per day, without regard to meals. Neuropathic Pain - Peripheral Neuropathic Pain: Starting dose is 150 mg per day; after 3 to 7 days, the dose may be increased to 300 mg per day, with a maximum of 600 mg allowed at 7-day intervals if necessary. - Central Neuropathic Pain: Starting dose is 150 mg per day; after 1 week, the dose may be increased to 300 mg per day.

Child dose

Due to insufficient safety and efficacy data, administration is not recommended for children under 12 years and adolescents aged 12-17.

This medication can increase the risk of suicidal thoughts or behavior; therefore, if mood changes or symptoms of depression occur during use, it should be reported to a healthcare professional immediately. Patients with hypersensitivity to this medication or lactose intolerance should not take it. Diabetic patients may need to adjust the dosage of blood glucose control medications due to weight gain after taking this medication. If symptoms of angioedema appear, this medication should be discontinued immediately. Elderly patients need to be careful due to an increased risk of accidents from dizziness or drowsiness, especially during the initial phase of treatment. There may be temporary blurred vision or changes in eyesight; if symptoms occur, consult a healthcare professional. If this medication is suddenly discontinued, withdrawal symptoms such as insomnia, headache, nausea, and anxiety may occur, so dosage should be tapered off gradually according to the healthcare professional's instructions. Due to the risk of drug abuse, patients with a history of drug abuse should take this medication particularly cautiously. Patients with reduced kidney function may need dosage adjustments for this medication. Patients with heart disease should be cautious when taking this medication. Caution is advised when taking this medication with other drugs that have central nervous system depressant effects, due to the risk of respiratory suppression. In early pregnancy, there is a risk of fetal malformation; therefore, women of childbearing age should use effective contraceptive methods, and this medication should preferably not be administered during pregnancy. Breastfeeding women should avoid breastfeeding or consult a healthcare professional, as this medication is excreted in breast milk. This medication can cause dizziness and drowsiness, necessitating caution when driving or operating hazardous machinery. Severe skin reactions may occur rarely; if any skin abnormalities arise, discontinue this medication immediately and consult a healthcare professional. In case of overdose, symptoms such as confusion, drowsiness, and depression may appear, and treatment such as blood dialysis may be required. Keep out of reach of children or others, and do not transfer to another container.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, paleness, severe rash with high fever, blisters, skin peeling, oral/ocular mucosal pain, shortness of breath or respiratory difficulty, asthma attacks, cough with fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, vision disturbances, paralysis, urinary changes.

Mild side effects

• Dizziness
• drowsiness
• confusion
• spatial disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to maintain a storage temperature between 15 degrees and 30 degrees Celsius.

Appearance

Hard capsule with a dark brown upper and white lower section containing a white powder.

Package unit

30 capsules/bottle, 60 capsules/bottle